Skip to content
Home/Companies/MedTech/LimFlow

LimFlow

MedTech·France·Exited 2023·Held 5yr
Entry
2018
Hold
5yr
Exit
2023

Who owns LimFlow?

LimFlow is a French MedTech company, now owned by Inari Medical, which acquired it in 2023 from Sofinnova Partners.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Sofinnova Partners
Investor
Sofinnova Partners
Sofinnova MD Start · 2010 · VC

Key facts

HQFrance
SectorMedTech
Exit Type
Trade Sale
Buyer
Inari Medical
Exit Year
2023

More from Sofinnova MD Start

Other portfolio companies in the same fund.

Gradient Denervation Technologies
Gradient Denervation Technologies
Active
MedTechUS· 2023
Julier Medical
Active
MedTechFrance· 2023
BrightHeart
BrightHeart
Active
MedTechFrance· 2022
HEPTA Medical
HEPTA Medical
Active
MedTechFrance· 2022
Tulyp Medical
Active
MedTechFrance· 2022
Endoron Medical
Endoron Medical
Active
MedTechFrance· 2021

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany

Questions

Who owns LimFlow?

LimFlow is now owned by Inari Medical, which acquired it in 2023 from Sofinnova Partners.

When did Inari Medical acquire LimFlow?

Inari Medical acquired LimFlow in 2023, buying from Sofinnova Partners.

Who did LimFlow sell to?

Sofinnova Partners sold LimFlow to Inari Medical in 2023 (Trade Sale).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue